Literature DB >> 27986786

Novel lncRNA T-UCR as a potential downstream driver of the Wnt/β-catenin pathway in hepatobiliary carcinogenesis.

Maite G Fernández-Barrena1,2, Maria J Perugorria2,3,4, Jesus M Banales2,3,4.   

Abstract

Entities:  

Keywords:  BILARY DUCT CARCINOMA; CELL PROLIFERATION; HEPATOBILIARY CANCER; HEPATOCELLULAR CARCINOMA

Mesh：

Substances：

Year:  2016        PMID： 27986786     DOI： 10.1136/gutjnl-2016-312899

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  14 in total

1.  EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway.

Authors:  Ting Lei; Xiaodong Zhu; Kai Zhu; Fuxin Jia; Siqiao Li
Journal:  Cancer Biol Ther       Date:  2019-03-31       Impact factor: 4.742

2.  LncRNAs Associated with Chemoradiotherapy Response and Prognosis in Locally Advanced Rectal Cancer.

Authors:  Yiyi Zhang; Bingjie Guan; Yong Wu; Fan Du; Jinfu Zhuang; Yuanfeng Yang; Guoxian Guan; Xing Liu
Journal:  J Inflamm Res       Date:  2021-11-27

3.  Ischemic Stroke Alters the Expression of the Transcribed Ultraconserved Regions of the Genome in Rat Brain.

Authors:  Suresh L Mehta; Raghu Vemuganti
Journal:  Stroke       Date:  2018-03-16       Impact factor: 7.914

4.  The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1.

Authors:  Feng Su; Wang He; Changhao Chen; Mo Liu; Hongwei Liu; Feiyuan Xue; Junming Bi; Dawei Xu; Yue Zhao; Jian Huang; Tianxin Lin; Chun Jiang
Journal:  Cell Death Dis       Date:  2018-02-14       Impact factor: 8.469

5.  Down-regulation of lncRNA CASC2 promotes cell proliferation and metastasis of bladder cancer by activation of the Wnt/β-catenin signaling pathway.

Authors:  Zhijun Pei; Xian Du; Yafeng Song; Lin Fan; Fuyan Li; Yan Gao; Ruimin Wu; Yijia Chen; Wei Li; Hong Zhou; Yi Yang; Jing Zeng
Journal:  Oncotarget       Date:  2017-03-14

6.  LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling.

Authors:  Ji Liu; Rui Xu; Shi-Juan Mai; Yu-Shui Ma; Mei-Yin Zhang; Ping-Sheng Cao; Nuo-Qing Weng; Rui-Qi Wang; Di Cao; Wei Wei; Rong-Ping Guo; Yao-Jun Zhang; Li Xu; Min-Shan Chen; Hui-Zhong Zhang; Long Huang; Da Fu; Hui-Yun Wang
Journal:  Theranostics       Date:  2020-06-12       Impact factor: 11.556

7.  Knockdown of long non-coding RNA LCPAT1 inhibits autophagy in lung cancer.

Authors:  Xiao Yu; Xiaofei Ye; Hongyan Lin; Nannan Feng; Sumeng Gao; Xiaohong Zhang; Yu Wang; Herbert Yu; Xiaobei Deng; Biyun Qian
Journal:  Cancer Biol Med       Date:  2018-08       Impact factor: 4.248

Review 8.  The emergence of long non-coding RNAs in hepatocellular carcinoma: an update.

Authors:  Li Peng; Xiao-Qing Yuan; Chao-Yang Zhang; Jiang-Yun Peng; Ya-Qin Zhang; Xi Pan; Guan-Cheng Li
Journal:  J Cancer       Date:  2018-06-22       Impact factor: 4.207

Review 9.  Regulation of microRNAs function by circular RNAs in human cancer.

Authors:  Chao Han; Nicole A Seebacher; Francis J Hornicek; Quancheng Kan; Zhenfeng Duan
Journal:  Oncotarget       Date:  2017-08-04

10.  A three-long non-coding RNA-expression-based risk score system can better predict both overall and recurrence-free survival in patients with small hepatocellular carcinoma.

Authors:  Jingxian Gu; Xing Zhang; Runchen Miao; Xiaohua Ma; Xiaohong Xiang; Yunong Fu; Chang Liu; Wenquan Niu; Kai Qu
Journal:  Aging (Albany NY)       Date:  2018-07-13       Impact factor: 5.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.